164 related articles for article (PubMed ID: 25808077)
1. The Loss of BKV-specific Immunity From Pretransplantation to Posttransplantation Identifies Kidney Transplant Recipients at Increased Risk of BKV Replication.
Schachtner T; Stein M; Babel N; Reinke P
Am J Transplant; 2015 Aug; 15(8):2159-69. PubMed ID: 25808077
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory activation and recovering BKV-specific immunity correlate with self-limited BKV replication after renal transplantation.
Schachtner T; Stein M; Sefrin A; Babel N; Reinke P
Transpl Int; 2014 Mar; 27(3):290-301. PubMed ID: 24279642
[TBL] [Abstract][Full Text] [Related]
3. CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor.
Schachtner T; Stein M; Reinke P
Transplantation; 2017 Oct; 101(10):e315-e325. PubMed ID: 28594749
[TBL] [Abstract][Full Text] [Related]
4. ABO desensitization affects cellular immunity and infection control after renal transplantation.
Schachtner T; Stein M; Reinke P
Transpl Int; 2015 Oct; 28(10):1179-94. PubMed ID: 26033637
[TBL] [Abstract][Full Text] [Related]
5. Different risk factor profiles distinguish early-onset from late-onset BKV-replication.
Schachtner T; Babel N; Reinke P
Transpl Int; 2015 Sep; 28(9):1081-91. PubMed ID: 25959355
[TBL] [Abstract][Full Text] [Related]
6. Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.
Schachtner T; Stein M; Reinke P
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28296035
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of BK virus-specific interferon-γ enzyme-linked immunospot assay for predicting the outcome of BK virus infection in kidney transplant recipients.
Bae H; Na DH; Chang JY; Park KH; Min JW; Ko EJ; Lee H; Yang CW; Chung BH; Oh EJ
Korean J Intern Med; 2021 Jan; 36(1):164-174. PubMed ID: 32241081
[TBL] [Abstract][Full Text] [Related]
8. Kidney transplant recipients after nonrenal solid organ transplantation show low alloreactivity but an increased risk of infection.
Schachtner T; Stein M; Reinke P
Transpl Int; 2016 Dec; 29(12):1296-1306. PubMed ID: 27638250
[TBL] [Abstract][Full Text] [Related]
9. Diabetic kidney transplant recipients: Impaired infection control and increased alloreactivity.
Schachtner T; Stein M; Reinke P
Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28423197
[TBL] [Abstract][Full Text] [Related]
10. BK Polyomavirus Micro-RNAs: Time Course and Clinical Relevance in Kidney Transplant Recipients.
Demey B; Descamps V; Presne C; Helle F; Francois C; Duverlie G; Castelain S; Brochot E
Viruses; 2021 Feb; 13(2):. PubMed ID: 33672313
[TBL] [Abstract][Full Text] [Related]
11. Antigen-specific T cell responses to BK polyomavirus antigens identify functional anti-viral immunity and may help to guide immunosuppression following renal transplantation.
Chakera A; Bennett S; Lawrence S; Morteau O; Mason PD; O'Callaghan CA; Cornall RJ
Clin Exp Immunol; 2011 Sep; 165(3):401-9. PubMed ID: 21671906
[TBL] [Abstract][Full Text] [Related]
12. Preformed donor-reactive T cells that persist after ABO desensitization predict severe T cell-mediated rejection after living donor kidney transplantation - a retrospective study.
Schachtner T; Stein M; Otto NM; Reinke P
Transpl Int; 2020 Mar; 33(3):288-297. PubMed ID: 31696547
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulins do not prove beneficial to reduce alloimmunity among kidney transplant recipients with BKV-associated nephropathy.
Naef B; Nilsson J; Wuethrich RP; Mueller TF; Schachtner T
Transpl Int; 2021 Aug; 34(8):1481-1493. PubMed ID: 33872427
[TBL] [Abstract][Full Text] [Related]
14. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients.
Ginevri F; Azzi A; Hirsch HH; Basso S; Fontana I; Cioni M; Bodaghi S; Salotti V; Rinieri A; Botti G; Perfumo F; Locatelli F; Comoli P
Am J Transplant; 2007 Dec; 7(12):2727-35. PubMed ID: 17908275
[TBL] [Abstract][Full Text] [Related]
15. The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.
Verghese PS; Schmeling DO; Knight JA; Matas AJ; Balfour HH
Transplantation; 2015 Mar; 99(3):602-8. PubMed ID: 25148381
[TBL] [Abstract][Full Text] [Related]
16. Nucleic Acid Tests for BK Polyomavirus Is Critical in Renal Transplant Recipients.
Chang YL; Cheng YT; Chen TC; Chien YS; Lee WC; Shen YC
Transplant Proc; 2018 Oct; 50(8):2489-2492. PubMed ID: 30316383
[TBL] [Abstract][Full Text] [Related]
17. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous pancreas/kidney transplant recipients are predisposed to tissue-invasive cytomegalovirus disease and concomitant infectious complications.
Schachtner T; Zaks M; Otto NM; Kahl A; Reinke P
Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28665480
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous pancreas/kidney transplant recipients present with late-onset BK polyomavirus-associated nephropathy.
Schachtner T; Zaks M; Kahl A; Reinke P
Nephrol Dial Transplant; 2016 Jul; 31(7):1174-82. PubMed ID: 26758790
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T Cell Immune Response to VP1 and VP3 in BK Virus Infected Recipients of Renal Transplantation.
Fan Y; Bai H; Qian Y; Sun Z; Shi B
Surg Infect (Larchmt); 2019 Apr; 20(3):236-243. PubMed ID: 30707648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
